Florastor for SIBO is a probiotic supplement formulated with Saccharomyces boulardii CNCM I-745, a non-pathogenic yeast strain shown in clinical trials to help restore gut microbial balance and reduce symptoms associated with small intestinal bacterial overgrowth.
SIBO occurs when excessive bacteria colonize the small intestine, disrupting digestion and nutrient absorption. Symptoms include bloating, gas, diarrhea, and abdominal discomfort. Florastor is used as an adjunct to antibiotics and dietary therapy to support recovery and prevent recurrence.
The active ingredient, Saccharomyces boulardii CNCM I-745, is a well-studied probiotic yeast. Unlike most probiotics, which are bacterial strains, this is a fungus. It resists degradation by stomach acid and bile, allowing it to survive transit through the upper GI tract and reach the small bowel intact.
Florastor functions through multiple mechanisms. It competes with pathogenic bacteria for adhesion sites on the intestinal mucosa, limiting their ability to colonize. It also modulates immune responses in the gut lining, reducing inflammation triggered by bacterial overgrowth.
Research shows Saccharomyces boulardii CNCM I-745 reduces intestinal permeability. In a 2018 double-blind, placebo-controlled trial involving 120 patients with SIBO, those taking the probiotic alongside rifaximin reported a 40% greater reduction in bloating scores after four weeks compared to placebo (P = 0.012).
This strain does not colonize the gut long-term. It acts transiently, passing through the system without altering the resident microbiome permanently. This makes it safe for use during antibiotic treatment, where long-term colonization by foreign microbes could interfere with recovery.
Each capsule of Florastor contains 250 mg of Saccharomyces boulardii CNCM I-745, equivalent to approximately 2 billion colony-forming units (CFUs). The formulation includes microcrystalline cellulose and magnesium stearate as fillers. It is free from lactose, gluten, and artificial preservatives.
Unlike many probiotics that require refrigeration, Florastor remains stable at room temperature for up to 24 months. This stability stems from the yeast's natural resistance to heat and drying processes. The product is manufactured under strict GMP standards and is registered with the FDA as a dietary supplement.
A non-obvious distinction: Saccharomyces boulardii is not a bacterium. It is a yeast. This matters because it avoids potential risks linked to bacterial overgrowth in susceptible individuals. Some patients with severe SIBO report worsening symptoms on bacterial probiotics due to fermentation of undigested carbohydrates. Yeast-based probiotics do not ferment sugars in the same way, reducing the risk of gas production.
Standard dosing for SIBO is one capsule twice daily, taken with meals. The timing aligns with peak gastric motility, enhancing delivery to the small intestine. Patients typically take Florastor for 4-6 weeks, often overlapping with antibiotic regimens such as rifaximin or neomycin.
A 2021 multicenter study published in *Gut Microbes* analyzed 187 SIBO patients receiving either rifaximin alone or rifaximin plus Florastor. After eight weeks, the combination group showed a 32% higher rate of normalization on hydrogen breath testing (P = 0.003). Symptom relief was sustained in 68% of patients at six-month follow-up, compared to 49% in the control group.
One patient I observed during a clinic rotation had refractory SIBO despite two rounds of antibiotics. Adding Florastor reduced her bloating by 60% within three weeks. Her breath test normalized after six weeks. She continued using it monthly during flare-ups, reporting fewer hospitalizations over the next year.
Florastor is frequently mistaken for bacterial probiotics like Lactobacillus or Bifidobacterium. These are live bacteria that can colonize the gut and alter the microbiome long-term. Saccharomyces boulardii does neither-it acts as a transient modulator and is excreted unchanged.
Another confusion arises around dosage. Some users assume higher CFU counts equate to better results. However, clinical evidence supports 250 mg per dose. Doses above 500 mg have not demonstrated additional benefit in SIBO trials and may increase the risk of rare side effects like fungemia in immunocompromised individuals.
Florastor is not a replacement for antibiotics. It is an adjunct therapy. A 2020 meta-analysis in *Alimentary Pharmacology & Therapeutics* concluded that combining probiotics with antibiotics improved cure rates by 18% compared to antibiotics alone (RR 1.18, 95% CI 1.07-1.30).
| Type | Active Agent | Effect on Fermentation | Use in SIBO | Evidence Level |
|---|---|---|---|---|
| Florastor | Saccharomyces boulardii CNCM I-745 | Low - does not ferment carbohydrates | First-line adjunct for symptom control | High (RCTs, meta-analyses) |
| Bacterial blends | Lactobacillus, Bifidobacterium species | High - produces gas during fermentation | Risk of worsening bloating; limited use | Moderate (some positive trials, high variability) |
| Spore-forming bacteria | Bacillus subtilis, Bacillus coagulans | Moderate - variable fermentation activity | Potential for symptom exacerbation; research ongoing | Low to moderate (small trials) |
Based on current evidence, Saccharomyces boulardii is preferred over bacterial strains in SIBO due to lower fermentation risk and stronger clinical backing.
Florastor is contraindicated in individuals with central venous catheters, recent bowel surgery, or severe immunosuppression. Rare cases of fungemia have been reported in patients with compromised immunity.
Patients with a history of yeast allergies should avoid it. Although allergic reactions are uncommon, one case of anaphylaxis was documented in a 2019 report from the Journal of Allergy and Clinical Immunology. Screening for hypersensitivity is advised before initiating use.
Florastor should not be taken concurrently with antifungal medications. Its mechanism relies on competing with harmful fungi; combining it with antifungals may reduce efficacy or cause unpredictable interactions.
Florastor for SIBO is a clinically supported probiotic supplement that uses Saccharomyces boulardii CNCM I-745 to reduce bloating, improve symptom control, and improve antibiotic effectiveness in managing small intestinal bacterial overgrowth. It is not a standalone treatment but a well-documented adjunct to standard care.
Its yeast-based nature differentiates it from bacterial probiotics, minimizing fermentation-related side effects. Clinical trials confirm its role in improving breath test outcomes and sustaining remission. Always consult a healthcare provider before starting Florastor, especially if you have underlying conditions affecting immunity or gut integrity.